Lotus Bio-Technology Development (LBTD) Income Statement

8 Followers

Lotus Bio-Technology Development Income Statement

Last quarter (Q3 2018), Lotus Bio-Technology Development's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lotus Bio-Technology Development's net income was $-622.00. See Lotus Bio-Technology Development’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Mar 17
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 19.55K
Depreciation and Amortization	$ 1.09K
EBITDA	$ -19.55K
Operating Income	$ -19.55K
Other Income/Expenses	$ 0.00
Pretax Income	$ -19.55K
Net Income	$ -19.55K
Per Share Metrics
Basic EPS	$ >-0.01
Diluted EPS	$ >-0.01
Weighted Average Shares Outstanding	82.78M
Weighted Average Shares Outstanding (Diluted)	82.78M

Currency in USD

Lotus Bio-Technology Development (LBTD) Income Statement

Lotus Bio-Technology Development Income Statement

Lotus Bio-Technology Development Earnings and Revenue History